Revolutionary nanotechnology platform delivering targeted joint pain relief, cartilage protection, and disease modification for comprehensive osteoarthritis management
Multi-modal nanotechnology platform addressing pain, inflammation, and disease progression in osteoarthritis
Advanced topical formulations with deep joint penetration for localized osteoarthritis pain and inflammation management.
Direct joint injection therapy with enhanced bioavailability and extended duration for severe OA cases.
Breakthrough formulations targeting cartilage degradation and promoting joint health preservation.
Integrated treatment approach combining pain relief with functional improvement and quality of life enhancement.
Complete care pathway from early intervention to advanced disease management
Proactive intervention strategies for patients at risk of developing osteoarthritis or showing early symptoms.
Targeted treatment for patients experiencing joint pain and early functional limitations with minimal cartilage damage.
Advanced interventions for patients with significant joint damage, severe pain, and functional impairment.
Ongoing support and maintenance therapy to preserve joint health and maintain quality of life over time.
Our nanotechnology platform delivers salsalate directly to affected joint tissues, targeting multiple pathways involved in osteoarthritis pathogenesis and progression.
The nanoformulated approach enables precise targeting of inflammatory mediators, cartilage-degrading enzymes, and pain pathways while protecting healthy joint structures.
This multi-target strategy addresses both symptoms and underlying disease mechanisms, offering comprehensive osteoarthritis management beyond traditional approaches.
Targeted reduction of pro-inflammatory cytokines and mediators
Prevention of matrix metalloproteinase-mediated cartilage degradation
Direct inhibition of pain signaling pathways in joint tissues
Promotion of chondrocyte survival and matrix synthesis
Significant improvements in pain, function, and quality of life for osteoarthritis patients
Significant reduction in WOMAC pain scores and daily discomfort levels
Improved walking distance, stair climbing, and activities of daily living
Reduced cartilage loss and joint space narrowing progression
High patient satisfaction with symptom relief and functional improvement
Decreased reliance on NSAIDs and other systemic pain medications
Americans diagnosed with osteoarthritis who could benefit from treatment
Partner with us to bring breakthrough osteoarthritis treatments to patients. Join leading rheumatologists and orthopedic specialists in transforming joint health through innovative nanotechnology.